MedTrace Logo

Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)

NCT02246634 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 282

Last updated 2024-10-17

No results posted yet for this study

Summary

Eligible patients with high risk colorectal malignancy (T3/4, spread greater than 5mm, EMVI positive) will have additional surveillance of breath hold T1, T2 and DW-MRIs (no IV contrast) post surgery six monthly for three years.

Findings of liver MRIs as reported by radiology PI will be shared with their local MDT who make decisions as appropriate, including the management of any identified liver metastases, according to local protocol.

Conditions

  • Colorectal Neoplasms
  • Neoplasm Metastases
  • Hepatic Neoplasms

Interventions

OTHER

Diffusion Weighted MRI scan

Liver metastases found on the additional DW-MRI scans will be discussed at MDT and treated according to local site policy.

Sponsors & Collaborators

  • Pelican Cancer Foundation

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Gina Brown · Imperial College London

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2026-12-31
Completion
2031-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02246634 on ClinicalTrials.gov